Drug and pharmaceutical recalls
354 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
Recent recalls
Page 1 of 12- Unichem amiodarone tablets recalled for foreign substance
Unichem Pharmaceuticals USA Inc. is recalling one lot of Amiodarone Hydrochloride Tablets, USP, 200 mg, 60-tablet bottles, because the product contains a foreign substance. The FDA classifies this as a Class II recall. No injuries have been reported.
ModerateFDANov 13, 2026Unichem Pharmaceuticals
10 Day Forecast capsules recalled for undeclared sildenafil, acetaminophenGame Changer Products LLC is voluntarily recalling all lots of 10 Day Forecast capsules sold as a male sexual enhancement product. FDA analysis found the product contains undeclared sildenafil and acetaminophen. The notice says sildenafil may interact with nitrate drugs such as nitroglycerin and cause a dangerous drop in blood pressure, and acetaminophen may cause serious liver damage in people already taking acetaminophen products.
SeriousFDANov 12, 2026Game Changer Products
- Advagen metoprolol tartrate tablets recalled for foreign tablets
Advagen Pharma is recalling one batch of metoprolol tartrate tablets, 50 mg, in 1,000-count bottles, because of the presence of foreign tablets or capsules. No injuries have been reported.
ModerateFDANov 10, 2026Advagen Pharma
Eugia vancomycin injection recalled for glass particle contaminationEugia US LLC is voluntarily recalling one lot of Vancomycin Hydrochloride for Injection USP 1.25g/30mL single-dose vials because a glass particle was found inside a vial. The notice says use of product containing glass particles can cause serious harm, including blood clots, permanent organ damage, or death. The company has not received any reports of adverse events related to this recall.
SeriousFDANov 6, 2026Eugia
- ORL toothpaste and mouthwash recalled for hormone cross-contamination
ORL Labs is recalling six ORL Organic Oral Care kids' and adult toothpaste and mouthwash products sold nationwide. The FDA's sampling found progesterone, estradiol, or DHEA (a hormone) in the products, which the company says is due to cross-contamination. No injuries have been reported.
ModerateFDANov 6, 2026ORL Labs6 products
- Sun Pharmaceutical lisdexamfetamine capsules recalled for failed dissolution
Sun Pharmaceutical Industries is recalling 17,760 bottles of lisdexamfetamine dimesylate capsules 40 mg, 100-count, because they failed dissolution specifications. The bottles were distributed in Ohio and Mississippi. No injuries have been reported.
ModerateFDANov 6, 2026Sun Pharmaceutical
- American Health Packaging cyanocobalamin recalled for possible glass particles
American Regent notified BluePoint Laboratories of potential glass particle contamination in a batch of cyanocobalamin injection, USP, 1,000 mcg/mL, sold in 25-vial cartons. The recall covers lot 24394A, expiration 10-31-2026, with about 4,097 cartons distributed nationwide. No injuries have been reported.
ModerateFDANov 5, 2026American Health Packaging
- American Regent cyanocobalamin injection recalled for glass particulate matter
American Regent is recalling one lot of Cyanocobalamin Injection, USP, 1000 mcg/mL, in 25 x 1 mL multi-dose vials. The recall notice identifies the particulate matter in the product as glass. The product was distributed nationwide, and no injuries have been reported.
ModerateFDANov 4, 2026American Regent
- Tridacaine III lidocaine patch recalled for incorrect expiration date
Trifluent Pharma is recalling Tridacaine III Lidocaine Patch 5%, lot L2606225A, because the label prints an incorrect expiration date. The label shows 06/22/2029. No injuries have been reported.
FDANov 4, 2026Trifluent Pharma2 products
- DELFLEX dialysis solution recalled for possible sterility risk
Fresenius Medical Care is recalling certain lots of DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, 2,000 mL single-dose bags with an attached stay safe Exchange Set. Complaints reported potential leaks from small perforations in the print area of the primary bag, so the solution may not be sterile. No injuries have been reported.
ModerateFDANov 3, 2026NxStage5 products
- Hikma ciprofloxacin tablets recalled for N-nitroso-ciprofloxacin above limit
Hikma Pharmaceuticals USA Inc. is recalling 29,085 bottles of Ciprofloxacin Tablets, USP, 500 mg, 100-count. The FDA found N-nitroso-ciprofloxacin levels above its recommended interim control limit, a problem under current good manufacturing practice (CGMP) rules. No injuries have been reported.
ModerateFDANov 3, 2026Hikma Pharmaceuticals2 products
- Tychasis Coats aloe products recalled for failed stability tests
BioMed Laboratories is recalling three Tychasis Coats products: aloe lotion (allantoin 0.5%), aloe creme (allantoin 0.5%) and aloe liniment (methyl salicylate 10%), in several bottle and jar sizes. The FDA reports that stability test results for viscosity and appearance did not align with the established specifications. The products were distributed in Texas only, and no injuries have been reported.
ModerateFDANov 2, 2026BioMed Laboratories3 products
- Preferred Pharmaceuticals eye drops recalled for sterility risk
Preferred Pharmaceuticals is recalling certain lots of Artificial Tears Lubricant Eye Drops (labeled Visine, made by Geri-Care in Brooklyn, NY) because the manufacturer cannot assure the product is sterile. About 480 bottles were distributed nationwide. No injuries have been reported.
ModerateFDAOct 30, 2026Preferred Pharmaceuticals
- AvKARE fludrocortisone tablets recalled for failed impurity specs
AvKARE is recalling one lot of fludrocortisone acetate 0.1 mg tablets because testing found impurity or degradation levels above required limits. The recall covers lot 48353 (expiration 10/31/2026) in 50-tablet unit-dose cartons, NDC 50268-330-15, distributed nationwide. No injuries have been reported.
ModerateFDAOct 30, 2026AvKARE
- Brevital Sodium injection recalled for particulate matter
Par Health USA is recalling certain lots of Brevital Sodium (methohexital sodium) for injection, a 500 mg multiple-dose vial sold in the US and Canada. The vials may contain particles identified as cellulose. No injuries have been reported.
SeriousFDAOct 30, 2026Paragon 28
- Victory Medical Center injectables recalled for lack of processing controls
Victory Medical Center Pharmacy is recalling 42 injectable vial products because of a lack of processing controls. The products were distributed in Colorado, Florida, and Texas, and include alpha lipoic acid, ascorbic acid, B complex, BPC-157, CJC-1295, dexamethasone, methylcobalamin, and NAD+, among others. No injuries have been reported.
ModerateFDAOct 30, 2026Victory Medical Center Pharmacy42 products
- Novadoz atorvastatin 40mg tablets recalled for foreign tablet contamination
Novadoz Pharmaceuticals is recalling about 13,296 bottles of 1,000-count atorvastatin calcium 40mg tablets distributed nationwide. Some bottles may contain other tablets or capsules that are not atorvastatin. No injuries have been reported.
ModerateFDAOct 29, 2026MSN Laboratories
- Brandywine theophylline ER tablets recalled for stability testing lapse
Brandywine Pharmaceuticals is recalling one lot of theophylline extended-release tablets, 100 mg, because stability testing for the product was interrupted at a third-party lab. Stability testing checks whether a medicine stays within its quality standards over time. No injuries have been reported.
ModerateFDAOct 29, 2026Brandywine Pharmaceuticals2 products
- Meitheal vecuronium bromide recalled for missing warning label
Meitheal Pharmaceuticals is recalling about 121,800 vials of Vecuronium Bromide for Injection, 10 mg, because the labels lack a required warning or prescription legend. No injuries have been reported. The FDA classified this as a Class III recall, which means it is unlikely to cause serious harm.
FDAOct 29, 2026Meitheal Pharmaceuticals2 products
- Direct Rx lidocaine ointment recalled for subpotency
Direct Rx is recalling 493 jars of Lidocaine Ointment USP, 5.0%, 50g, because the product may contain less lidocaine than its label states. The affected lots are 03AP2511, 30AP2518, 18JU2519, and 18JU2520, with an expiration date of 04/30/2027. The product was distributed nationwide, and no injuries have been reported.
ModerateFDAOct 29, 2026Direct Rx
- Eagle Pharma phenylephrine and oxytocin infusions recalled for sterility risk
Eagle Pharma Outsourcing is recalling two compounded IV infusion products nationwide: phenylephrine HCl (100 mg in 250 mL saline, 50 containers) and oxytocin (30 units in 500 mL saline, 5 containers). The company cannot assure that the products are sterile. No injuries have been reported.
ModerateFDAOct 28, 2026Eagle Pharma Outsourcing2 products
- AvKARE amitriptyline tablets recalled for failed dissolution
AvKARE is recalling one lot of amitriptyline hydrochloride 10 mg tablets because they failed dissolution specifications. The recall covers 3,534 cartons of 50-count unit dose cards distributed nationwide. No injuries have been reported.
ModerateFDAOct 28, 2026AvKARE
- Fei Fah Electric Medicated Balm recalled for manufacturing quality issues
Fei Fah Medical Manufacturing recalled its Ultra Strength Electric Medicated Balm because it did not meet FDA manufacturing quality standards (CGMP). The recall covers about 171,120 units sold nationwide in 70g and 10g sizes. No injuries have been reported.
ModerateFDAOct 27, 2026Fei Fah Medical Manufacturing
- Palm, Lynx, PRO CHEM and more soaps recalled for manufacturing issues
ABC Compounding Co. is recalling 19 antiseptic hand soap, antiseptic foam and hand-and-body wash products nationwide. The recall cites manufacturing practice violations (cGMP deviations), and no injuries have been reported. The products come from several makers and sellers, including ABC Compounding, and are sold under names such as Palm, Lynx, Aero Foamy, PRO CHEM and Chemseptic.
ModerateFDAOct 27, 2026ABC Compounding19 products
- Greenwich Rx glutathione injection recalled for microbial contamination
Greenwich Rx is recalling 4,319 vials of its 200 mg/mL glutathione injection (10 mL multi-dose vials, for subcutaneous use only) because they may be contaminated with microbes. The recall covers 12 lots with beyond-use dates from October 2 to November 26, 2026, distributed nationwide. No injuries have been reported.
SeriousFDAOct 27, 2026Greenwich Rx
- Par Argatroban injection recalled for particulate matter
Par Health USA's Argatroban Injection vials contain unwanted particles—including cellulose, polystyrene, plastic, stainless steel, or rubber stopper material—in the solution. The contamination affects multiple lot numbers distributed nationwide. No injuries have been reported.
SeriousFDAOct 26, 2026Paragon 282 products
- ValuHealth acetaminophen 500 mg recalled for incorrect inner label
ValuHealth Extra Strength Pain Relief Acetaminophen 500 mg bottles have an incorrect label on the bottle itself. The outer carton correctly says "Acetaminophen 500 mg," but the label on the bottle says "Pain Relief PM" — a different product. This mismatch could cause confusion about what you're taking.
ModerateFDAOct 26, 2026Prodose
- GSMS lubricant eye drops recalled for polyethylene-related impurities
GSMS Incorporated is recalling 30-count packs of Carboxymethylcellulose Sodium 0.5% Lubricant Eye Drops (NDC 51407-945-30), made by Huons Co., Ltd. in South Korea. Testing detected polyethylene (PE)-related oligomers, so the product failed its impurities and degradation specification. No injuries have been reported.
ModerateFDAOct 26, 2026Huons
- Strides Pharma cinacalcet tablets recalled for failed dissolution
Strides Pharma is recalling one lot of Cinacalcet 30 mg tablets because they failed to meet dissolution specifications, meaning the tablets may not break down properly in the body. This could result in inconsistent or reduced drug effectiveness. The affected lot is 7717825A, expiring 11/30/2028.
ModerateFDAOct 26, 2026Strides
- Macleods Pharma blood pressure tablets recalled for failed dissolution
Macleods Pharma USA is recalling specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide combination tablets (40 mg/10 mg/12.5 mg) because they failed to meet dissolution specifications. This means the tablets may not break down properly in the body, potentially reducing how well the medication works.
ModerateFDAOct 26, 2026MacLeods Pharma